Mark G Alexandrow

56PUBLICATIONS
278CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Pacific Peoples youth and family
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Sep 15, 2026
Circulating Tumor DNA Profiling Defines Risk Classification in Patients With Ewing Sarcoma: A Report From the Children's Oncology Group and the LEOPARD Study.

|Aug 19, 2026
Paediatric therapeutic development workshop on osteosarcoma.

|May 14, 2026
PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network Study.

|May 04, 2026
Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma.

|Apr 23, 2026
Does Longitudinal Targeted Panel Sequencing Provide Clinically Relevant Information in Translocation-Associated Sarcomas?

|Feb 12, 2026
Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma.

Evan Rosenbaum, Fiona Ehrich, Mohammad Yosofvand

Pageof 10

Frequent Collaborators

10 joint publications

Katherine A Janeway

8 joint publications

Brian D Crompton

8 joint publications

Richard Gorlick

8 joint publications

Steven G DuBois